Search results
Results from the WOW.Com Content Network
Hypertrophic Osteodystrophy (HOD) is a bone disease that occurs most often in fast-growing large and giant breed dogs; however, it also affects medium breed animals like the Australian Shepherd. The disorder is sometimes referred to as metaphyseal osteopathy , and typically first presents between the ages of 2 and 7 months. [ 1 ]
The HS complex of diseases is best recognized in the Bernese Mountain Dog in which a familial association is apparent. Other breeds are predisposed to HS complex diseases and include Rottweilers, Golden Retrievers, and Flat-coated Retrievers. Although HS complex is not limited to just these breeds and can occur sporadically in any breed.
C-reactive protein (CRP) is an annular (ring-shaped) pentameric protein found in blood plasma, whose circulating concentrations rise in response to inflammation. It is an acute-phase protein of hepatic origin that increases following interleukin-6 secretion by macrophages and T cells .
High-resolution computed tomography: HRT: hormone replacement therapy: h.s. at bedtime (from Latin hora somni) hs: hours of sleep H→S: heel-to-shin test HSC: human chorionic somatomammotropin (same as human placental lactogen) HSCT: Hematopoietic stem cell transplantation: HSG: hysterosalpingogram: HSIL: high-grade squamous intraepithelial ...
Many dogs may have lower resistance to infections because pandemic-era restrictions kept them out of day cares or boarding facilities and they weren’t exposed to circulating viruses or bacteria ...
This page was last edited on 10 March 2009, at 12:03 (UTC).; Text is available under the
Panosteitis, sometimes shortened to pano among breeders, [1] is an occasionally seen long bone condition in large breed dogs.It manifests with sudden, unexplained pain and lameness that may shift from leg to leg, usually between 5 and 14 months of age, earning the nickname "growing pains. "[2] Signs such as fever, weight loss, anorexia, and lethargy can also be seen.
The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP). JUPITER was the first clinical trial to indicate that statin therapy may provide benefit to patients with low-to-normal LDL levels and no known cardiovascular disease.